Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Chemotherapy-Related Cognitive ImpairmentDL-3-n-butylphthalide

Interventions

DRUG

DL-3-n-butylphthalide

Take butylphthalide soft capsules orally

DRUG

Empty Medication Capsules

Take empty medication capsules orally

All Listed Sponsors

lead

First Hospital of China Medical University

OTHER

NCT06508671 - Effects of DL-3-n-butylphthalide on Chemotherapy-Induced Cognitive Impairment | Biotech Hunter | Biotech Hunter